Inato is excited to announce our partnership with CRIO as part of their Partners Program. These partnerships are critical In the ever-evolving landscape of clinical research, collaborations that enhance efficiency for research sites are paramount.
CRIO’s Partners Program:
CRIO launched a Partners Program with the vision to connect clinical research sites to top-tier vendors. CRIO’s Partners Program serves as a bridge to innovative solutions aimed at optimizing clinical trial operations. By integrating with certified partners, CRIO empowers research sites with tools and services that elevate patient engagement, data management, and overall trial efficiency.
Inato’s Role in Transforming Clinical Trial Access
We are proud to be a pivotal player in this collaboration. Our platform is free for research sites and offers them the ability to:
- Discover Open and Upcoming Trials: Stay informed about the latest clinical trials, ensuring timely participation opportunities.
- Receive Personalized Trial Recommendations: Leverage tailored suggestions that align with the site’s specialties and capabilities.
- Highlight Unique Strengths to Sponsors: Showcase your diverse patient population, dedicated staff, and community involvement to increase visibility and attract sponsor interest.
- Pre-Screen Patients Faster: Quickly assess patient eligibility using intuitive AI tools that streamline matching, reduce site burden, and accelerate enrollment.
The integration of Inato into CRIO’s Partner Directory, particularly under the new Business Development and Feasibility category, simplifies the process for CRIO-affiliated sites to access and utilize Inato’s platform.
Unified Vision for Site-Centric Clinical Research
This partnership underscores a mutual commitment to a site-centric approach in clinical research. The collaboration seeks to empower research sites, ensuring they are well-equipped to connect with appropriate trials and sponsors seamlessly.
Research sites aiming to enhance their clinical trial participation and streamline operations, should explore the offerings of CRIO’s Partners Program and Inato’s platform as part of a strategic move toward the future of clinical trials.